MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugiyama, N.
Right arrow Articles by Taylor, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugiyama, N.
Right arrow Articles by Taylor, P.

Vol. 53, Issue 4, 787-794, April 1998

Residues at the Subunit Interfaces of the Nicotinic Acetylcholine Receptor That Contribute to alpha -Conotoxin M1 Binding

Naoya Sugiyama,1 Pascale Marchot,2 Chiaki Kawanishi,1 Hitoshi Osaka, Brian Molles, Steven M. Sine, and Palmer Taylor

Department of Pharmacology, University of California, San Diego, La Jolla, California 92093 (N.S., P.M., C.K., H.O., B.M., P.T.) and Department of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota 55455 (S.M.S.)

    Summary
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

The two binding sites in the pentameric nicotinic acetylcholine receptor of subunit composition alpha 2beta gamma delta are formed by nonequivalent alpha -gamma and alpha -delta subunit interfaces, which produce site selectivity in the binding of agonists and antagonists. We show by sedimentation analysis that 125I-alpha -conotoxin M1 binds with high affinity to the alpha -delta subunit dimers, but not to alpha -gamma dimers, nor to alpha , gamma , and delta  monomers, a finding consistent with alpha -conotoxin M1 selectivity for the alpha delta interface in the intact receptor measured by competition against alpha -bungarotoxin binding. We also extend previous identification of alpha -conotoxin M1 determinants in the gamma  and delta  subunits to the alpha  subunit interface by mutagenesis of conserved residues in the alpha  subunit. Most mutations of the alpha  subunit affect affinity similarly at the two sites, but Tyr93Phe, Val188Lys, Tyr190Thr, Tyr198Thr, and Asp152Asn affect affinity in a site-selective manner. Mutant cycle analysis reveals only weak or no interactions between mutant alpha  and non-alpha subunits, indicating that side chains of the alpha  subunit do not interact with those of the gamma  or delta  subunits in stabilizing alpha -conotoxin M1. The overall findings suggest different binding configurations of alpha -conotoxin M1 at the alpha -delta and alpha -gamma binding interfaces.

    Introduction
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Nicotinic acetylcholine receptors are pentamers of homologous subunits with composition alpha 2beta gamma delta that form a ring around a central channel (Galzi and Changeux, 1994; Karlin and Akabas, 1995). Two of its five subunit interfaces, alpha gamma and alpha delta , form binding sites for the neurotransmitter acetylcholine. These two binding interfaces are not identical in their affinities for agonists and competitive antagonists (Damle and Karlin, 1978; Neubig and Cohen, 1979; Weiland and Taylor, 1979; Sine and Taylor, 1981). Because the alpha  subunit is common to each binding interface, differences in affinity are attributed to the contributions of the gamma  and delta  subunits (Blount and Merlie, 1989; Petersen and Cohen, 1990, Sine and Claudio, 1991).

Recent studies showed that certain alpha -conotoxins, 12-14-amino acid disulfide-linked peptides isolated from venom of cone snails (Myers et al., 1991, 1993), bind with unusual selectivity to one of the two ligand binding sites on mouse and Torpedo californica receptors (Kreienkamp et al., 1994; Hann et al., 1994; Utkin et al., 1994; Groebe et al., 1995; Sine et al., 1995a). alpha -Conotoxin M1 binds with high affinity to the alpha delta site of the mouse receptor (KD = 0.5 nM), whereas it binds five orders of magnitude less tightly to the alpha gamma site (KD = 20 mM) (Kreienkamp et al., 1994; Sine et al., 1995a). alpha -Conotoxin Ml is unique in that its degree of selectivity is greater than for any known ligand, and its site preference is opposite to that of curariform antagonists, which bind more tightly to the alpha gamma site (Blount and Merlie, 1989; Petersen and Cohen, 1990; Sine and Claudio, 1991).

The high degree of sequence identity between the gamma  and delta  subunits suggests that the polypeptide chains of the two subunits fold into similar basic scaffolds. Thus residues in equivalent positions of the linear sequence are predicted to occupy similar positions in three dimensional space. This idea is supported by the striking finding that three residues in equivalent positions of the gamma  and delta  subunits confer virtually all of the selectivity for alpha -conotoxin Ml (Sine et al., 1995a). Residues in the alpha  subunit that stabilize alpha -conotoxin Ml have not been identified, but mutagenesis studies with agonists and antagonists revealed three regions of the alpha  subunit that contribute to the binding interface (Sine et al., 1994; Galzi et al., 1991; Middleton and Cohen, 1991; Tomaselli et al., 1991; O'Leary and White, 1994; O'Leary et al., 1994; Sugiyama et al., 1996). These three regions differ from binding site regions in the gamma  and delta  subunits, because they are predicted to be located on the opposite face of the subunit. In this study we employ radioiodinated alpha -conotoxin M1 to show directly that its binding requires an intact subunit interface; high affinity binding is found only at the alpha delta interface. We then examine through residue replacement the relationships between amino acid determinants in the alpha  subunit and those in the gamma  and delta  subunits that govern alpha -conotoxin M1 binding.

    Materials and Methods
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Radioiodination of conotoxin M1. alpha -Conotoxin M1 (American Peptide Co.), 0.75 nmol (1.125 mg), was iodinated at its single tyrosine (Tyr-12) with 0.1 mCi of Na125I (Amersham) and 2.5 mg of lactoperoxidase (Sigma) in 100 ml of a 50 mM NaPO4 buffer, pH 7.5. Free iodide was removed by selective adsorption on a Dowex 1X-8 (Bio-Rad) cationic resin (Marchot et al., 1993). Labeled alpha -conotoxin M1 was stored as a 0.5 mM solution in a 1:1 methanol:50 mM NaPO4 buffer, pH 7.5, at -20°. Dilute solutions (1 mM) were prepared in 1 mg/ml bovine serum albumin, 50 mM NaPO4, pH 7.5, stored at 4°, and used within the next 3 weeks. Specific activities of 100 Ci/mmol were achieved, which corresponded to 0.05 atom of iodine incorporated per molecule of alpha -conotoxin M1. The ratio of labeled species was kept low to minimize formation of diiodo-alpha -conotoxin M1.

Cell transfections. Human embryonic kidney 293 cells were transfected with cytomegalovirus-based expression vectors containing the respective cDNAs encoding the individual subunits by Ca3(PO4)2 precipitation (Sine, 1993; Kreienkamp et al., 1994). Typically plasmids containing cDNAs encoding alpha , beta , gamma , and delta  subunits in the weight ratio 2:1:1:1, and alpha , beta , and gamma , or alpha , beta , and delta  in the ratio of 2:1:2 were transfected. The transfections of cDNAs encoding the above four and three subunits yielded pentameric receptors alpha 2beta gamma delta , alpha 2beta gamma 2 or alpha 2beta delta 2 expressed at the cell surface (Sine and Claudio, 1991), whereas transfection of a cDNA encoding alpha  or delta  subunit and cotransfection of two cDNAs encoding alpha  and gamma  or alpha  and delta  required permeabilization of the cells to detect monomeric, dimeric, or tetrameric combinations of subunits within the cells (Green and Claudio, 1993; Kreienkamp et al., 1995).

Association of 125I-alpha -conotoxin M1 and 125I-alpha -bungarotoxin with isolated and assembled subunits. Three days after transfection, cells were harvested by gentle agitation in phosphate-buffered saline, pH 7.4, containing 5 mM EDTA. After low speed sedimentation, cells were permeabilized with saponin-containing buffer (10 mM, EDTA, 0.1% bovine serum albumin, and 0.5% saponin in 10 mM NaPO4, pH 7.4), and then incubated on ice with 5 nM 125I-alpha -bungarotoxin (specific activity of 8-16 mCi/mg; DuPont-New England Nuclear, Boston, MA) or with 125I-alpha -conotoxin M1 at the specified concentrations. Cells were then sedimented and washed free of excess unbound ligand with potassium Ringer's buffer. The pellets were solubilized on ice in 1.0% Triton X-100, 150 mM NaCl, 5 mM EDTA, 50 mM Tris·HCl, pH 7.5. After 4 hr, supernatants were layered over 3-30% sucrose gradients containing the same detergent buffer. Layered gradients were centrifuged in a Beckman SW41 rotor at 40,000 rpm for 22 hr at 4°. Fractions were collected and assayed; the S values were determined as previously described (Kreienkamp et al., 1995; Sugiyama et al., 1996).

alpha -Conotoxin competition with 125I-alpha -Bungarotoxin. Harvested cells were resuspended in potassium Ringer's buffer to measure ligand binding to receptors expressed on the cell surface. Specified concentrations of alpha -conotoxin M1 were added to each aliquot of cell suspension 60 min before measurement of the initial rate of 125I-alpha -bungarotoxin binding. The fractional reduction in the initial rate corresponds to the fractional occupation of sites by alpha -conotoxin M1 (Sine and Taylor, 1981; Sine et al., 1995a). KD values for each mutant are given as averages from two separate cell transfections. Sufficient cells were transfected to generate an entire concentration profile with duplicate samples measured at each concentration. The KDvalues typically varied by less than 20%.

Site-directed mutagenesis. Mutations of the individual subunits were generated by the method of Kunkel (1985); the entire mutagenic insert was sequenced to verify the mutation and rule out random polymerase errors.

    Results
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

125I-alpha -Conotoxin M1 binding to the receptor subunits. When cDNA encoding alpha  subunit is cotransfected with cDNAs encoding either the gamma  or delta  subunit, the resulting assembled subunits are retained within the cell. To detect association of labeled alpha -conotoxin, with monomeric subunits and the alpha gamma and alpha delta assembled oligomers, the cells were permeabilized with saponin, incubated with labeled toxin, washed, solubilized, and centrifuged into sucrose density gradients. The gradients resolve free toxin as well as labeled toxin associated with monomeric, dimeric, and tetrameric subunit oligomers (Fig. 1).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Sucrose density gradient profiles of 125I-alpha -Bungarotoxin (B1-B3) and 125I-alpha -conotoxin M1 (C1-C5) association with nicotinic acetylcholine receptors subunits. HEK cells were transfected with cDNAs encoding the respective subunits, alpha  (B1 and C1) and delta  (C2) subunits, or two subunit combinations alpha delta (B2 and C3) or alpha gamma (B3, C4, and C5). After 48 hr, cells were permeabilized with saponin. The respective radioiodinated toxins [~5 nM 125I-alpha -bungarotoxin, 20 nM 125I-alpha -conotoxin M1 (C1-C4), and 400 nM 125I-alpha -conotoxin M1 (C5)] were allowed to bind. Excess toxin was removed by washing and the cells solubilized with Triton X-100. The solubilized material was layered on a 5-30% sucrose gradient, and fractions collected from the top of the tubes and counted. Comparisons between 125I-alpha -conotoxin M1 and 125I-alpha -bungarotoxin binding for particular subunits were made from the same platings of transfected cells.

Analysis of HEK cells transfected with equivalent amounts of cDNAs encoding only the alpha  subunit, the alpha  and gamma  pairs or the alpha and delta  pairs resulted in 125I-alpha -bungarotoxin association with alpha  subunit, the assembled alpha gamma and alpha delta subunit dimers, and the alpha gamma alpha gamma tetramer (Fig. 1, B1-B3). In contrast, association of 125I-alpha -conotoxin M1 is detected only with the alpha delta dimer, but neither with the alpha gamma dimer nor with the alpha gamma alpha gamma tetramer (Fig. 1, C1-C4). The absence of a peak or shoulder corresponding to alpha  subunit monomer when cells were cotransfected with either alpha  and gamma  or alpha  and delta  pairs of cDNAs indicates that free subunit monomer does not bind 125I-alpha -conotoxin M1 with high affinity. To rule out the possibility that the delta  subunit rather than the alpha delta dimer is responsible for alpha -conotoxin binding, we examined 125I-alpha -conotoxin M1 association with the isolated delta  subunit where expression of delta  subunit after cDNA transfection has been confirmed with Western blot analysis using a delta  subunit specific monoclonal antibody (mAb166) (Keller S and Taylor P, unpublished observations). As shown in Fig. 1, C2, only a free toxin peak is observed indicating that 125I-alpha -conotoxin M1 does not associate with the delta  subunit monomer.

Selectivity of 20 nM 125I-alpha -conotoxin M1 for the alpha delta interface is revealed by the lack of dissociation of the complex as it migrates into the gradients. The results are consistent with previous studies of alpha -conotoxin M1 competition with 125I-alpha -bungarotoxin binding to the intact receptor on the cell surface and cell surface receptors devoid of either the gamma  or delta  subunit (Kreienkamp et al., 1994; Sine et al., 1995a). Even at 400 nM concentrations of 125I-alpha -conotoxin M1, binding to the alpha gamma subunit dimer could not be detected above background levels (Fig. 1, C5), yet parallel plates of cells expressing the alpha gamma subunit combination showed 125I-alpha -bungarotoxin association with alpha gamma dimer and alpha gamma alpha gamma tetramer (Fig. 1, B3).

Identification of alpha  subunit determinants for alpha -conotoxin M1 binding. Site-directed labeling and mutagenesis studies have defined three linearly distinct regions in the alpha  subunit (regions A-C) that contribute to the ligand binding site (Dennis et al., 1988; Galzi et al., 1991; Middleton and Cohen, 1991; Tomaselli et al., 1991; O'Leary and White, 1992; O'Leary et al., 1994; Sine et al., 1994; Fu and Sine, 1994; Keller et al., 1995). Each region, presumably existing as a loop at the subunit interface, contains conserved aromatic residues, including Y93, W149, Y190, and Yl98 (Fig. 2). Here we mutate residues in these three regions and measure changes in alpha -conotoxin M1 affinity. Most mutations are substitutions for the aromatic residues, but also include substitutions of residues differing between muscle and neuronal alpha  subunits. Binding of alpha -conotoxin M1 was measured by competition against the initial rate of 125I-alpha -bungarotoxin binding, as described previously (Sine and Taylor, 1981).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Amino acid sequences and studied residue mutations for the three domains in the alpha  subunit which contribute to ligand binding. Bold residues, mutations.

Mutation of conserved tyrosines in regions A, B, and C. Mutation of Y93, Y190, and Y198 to aliphatic hydroxyl side chains (S or T) reduces affinity for alpha -conotoxin M1 (Fig. 3 and Table 1). Furthermore, the Y190T and Y198T mutations result in a selective influence for the affinity of the alpha delta site is affected to much greater extent than the alpha gamma site. Removal of the aromatic hydroxyl at Y151, Y190, and Y198 has no effect on alpha -conotoxin M1 affinity, whereas the Y93F mutation enhances affinity in a site-selective manner, increasing affinity for the alpha gamma site without affecting the alpha delta site (Fig. 4 and Table 1). Thus, mutation of the four conserved tyrosines affects alpha -conotoxin affinity in a manner similar to other antagonists (O'Leary et al., 1994; Sine et al., 1994). Aliphatic hydroxyl substitutions dramatically reduce affinity for alpha -conotoxin as observed previously for agonists and antagonists, whereas the removal of the hydroxyl group by substitution of phenylalanine either has little influence or enhances affinity (Sine et al., 1994, 1995b; Tomaselli et al., 1991; O'Leary et al., 1994). Interestingly, Y93F increases affinity of alpha -conotoxin (Fig. 4), whereas Y198F enhances d-tubocurarine affinity (Fu and Sine, 1994; Sine et al., 1994).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   alpha -Conotoxin M1 competition with the initial rate of alpha -bungarotoxin association at cell surface nicotinic receptors after transfection of HEK cells with cDNAs encoding the component subunits. Cells were transfected with wild-type or mutant alpha  subunit cDNAs along with beta , gamma , and delta  cDNAs. After 48 hr, the cells were incubated with alpha -conotoxin M1 at the specified concentrations, and initial rates of 125I-alpha -bungarotoxin association were measured. A, bullet , wild-type alpha  subunit; triangle , Y190T; square , Y198T. B, bullet , wild-type alpha  subunit; diamond , D152N. A shows that the mutation in the alpha  subunit affects the high affinity, alpha delta interface more than the low affinity, alpha gamma interface. B shows a shift by the alpha D152N mutation only at the alpha delta interface. kobs and kmax are the bimolecular rate constants for 125I-alpha -bungarotoxin association in the presence and absence of alpha -conotoxin M1.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Dissociation constants for alpha -conotoxin M1 and nicotinic acetylcholine receptor complexes


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   alpha -Conotoxin M1 competition with the initial rate of alpha -bungarotoxin association at cell surface nicotinic receptors after cotransfection of the cDNAs encoding the individual subunits. cDNAs encoding wild-type (bullet ) or mutant V188K (square ), Y93F (triangle ) alpha  subunits along with specified combinations of other subunits were transfected into HEK cells and alpha -conotoxin M1 binding was measured on the cell surface as described in Methods. A, Wild-type alpha  subunits, V188K or Y93F mutant alpha  subunit with beta , gamma , and delta  subunits. B, Wild-type alpha  subunits, V188K or Y93F mutant alpha  subunits with beta  and delta  subunits. C, Wild-type alpha  subunits or V188K or Y93F mutant subunits with beta  and gamma  subunits. Dissociation constants were calculated assuming high and low affinity sites of equal population and are listed in Table 1. The assay is identical to that shown in Fig. 3.

Mutation of charged, aromatic, and proline residues in region C. alpha -Conotoxin M1 is amidated on its carboxyl-terminus, lacks negatively charged side chains, but contains three or four positively charged side chains depending on pH. We therefore focused on charged residues in loop C, which differ between muscle and neuronal alpha subunits (Fig. 2). Replacement of positively charged residues with R182V or K185E, or insertion of a positive charge with F189K, fails to affect alpha -conotoxin M1 affinity (Table 1). By contrast, inserting a positive charge with V188K selectively decreases alpha -conotoxin Ml affinity for the alpha gamma site without affecting affinity for the alpha delta site (Fig. 4 and Table 1). Thus, electrostatic interactions with alpha -conotoxin M1 seem localized to position 188 and specifically affect the alpha gamma site.

We looked for additional sources of stabilization in region C by studying the mutations W184Y and V188D. However, these mutations, one of which adds a negative charge, do not affect alpha -conotoxin M1 affinity (Table 1).

A small loop bounded by prolines at the 194 and 197 positions is a characteristic feature of the alpha 1 subunit, not found in neuronal alpha  subunits (Fig. 2). Deletion of P194 or the P194L substitution has little effect on alpha -conotoxin M1 binding. The P197I mutation reduces alpha -conotoxin M1 affinity 2-4-fold at both sites, whereas the T195E mutation also reduces alpha -conotoxin M1 affinity, primarily at the alpha delta site.

Mutations in loop B. Mutations of the conserved W149 and Y151 to phenylalanine do not significantly affect alpha -conotoxin Ml binding (Table 1). The lack of effect of W149F on alpha -conotoxin M1 affinity contrasts with the large reduction in agonist affinity associated with this mutation (Sine et al., 1994). Previous studies showed that D152N introduces a glycosylation consensus site that becomes glycosylated, and further that agonist and antagonist affinities are markedly reduced (Sugiyama et al., 1996). For alpha -conotoxin M1, D152N reduces affinity slightly for the alpha delta site without affecting the alpha gamma site. Thus, the aromatic residues examined in region B make no contribution to alpha -conotoxin M1 affinity, whereas the negative charge at position 152 enhances its affinity.

Mutagenesis of residues in both the alpha  subunits and non-alpha subunits. Previous studies identified three residues in equivalent positions of the gamma  and delta  subunits that confer higher affinity of alpha -conotoxin M1 for the alpha delta over the alpha gamma interface (Sine et al., 1995a). To account for the selective effect of alpha Y93F and alpha V188K for the alpha gamma interface, we reasoned that either alpha -conotoxin M1 affinity is enhanced by interaction between determinants in the alpha  and gamma subunits or alpha -conotoxin M1 orients differently at the alpha gamma and alpha delta interfaces. Thus we investigated these two possibilities by examining alpha -conotoxin Ml binding to receptors containing mutations in both the alpha  and gamma  subunits.

We first examined the site selective mutations alpha Y93F and alpha V188K incorporated into pentameric receptors lacking the delta  subunit. The resulting cell surface receptors have the composition alpha 2beta gamma 2, which should contain two equivalent alpha gamma binding sites (Sine and Claudio, 1991). Incorporating alpha Y93F into these pentamers increases alpha -conotoxin M1 affinity, whereas incorporating alpha V188K decreases affinity for both alpha gamma sites (Fig. 5A and Table 2), as observed for one of the two sites in alpha 2beta gamma delta pentamers (Fig. 4 and Table 1). Moreover, when coexpressed with the series of mutant gamma  subunits, the alpha Y93F and alpha V188K mutations affect alpha -conotoxin M1 affinity to the same extent as observed when coexpressed with the wild-type gamma  subunit (Fig. 5A). Thus, alpha Y93F and alpha V188K do not interact with residues in the gamma  subunit that confer selective binding of alpha -conotoxin M1.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 5.   Interrelationships in alpha -conotoxin M1 dissociation constants for alpha  subunit mutant receptors containing mutations in the gamma  and delta  subunits. Data are determined from concentration profiles similar to those shown in Figs. 3 and 4. A, Cotransfection of three subunits: alpha  (wild-type or mutant Y93F or V188K), wild-type beta , either wild-type or mutant gamma , or wild-type delta  were cotransfected. B, Cotransfection of four subunits: alpha  (wild-type or mutant Y93F or V188K), wild-type beta , wild-type or mutant gamma , and wild-type delta  were cotransfected. The dissociation constants determined are shown on a logarithmic plot relative to wild-type alpha  subunits.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
alpha -Conotoxin MI dissociation constants (KD) for wild-type and mutant nicotinic receptors expressed from three and four subunit combinations

KD values are averages from two separate transfections. In each transfection, a complete concentration profile is generated using duplicate sampling at each concentration (compare Figs. 3, 4, and 6). Transfection of alpha /beta /gamma /delta (2:1:1:1), alpha /beta /gamma (2:1:2), and alpha /beta /delta (2:1:2) in the specified cDNA ratios yields the above stoichiometry of subunits (Sine and Claudio, 1991; Sine 1993).

Curiously, neither alpha Y93F nor alpha V188K significantly affect affinity when paired with the wild-type delta  subunit and expressed as alpha 2beta delta 2. However, they affect affinity strongly when paired with the triple mutant of the gamma  subunit (gamma SYI) that increases affinity to approach that conferred by the delta  subunit (Fig. 5). These findings suggest that other residues unique to the delta  subunit nullify the effects of alpha Y93F and alpha V188K, perhaps by conferring a different orientation of alpha -conotoxin M1 at the alpha gamma and alpha delta interfaces. Alternatively, constraints imposed by the delta  subunit may preclude Y93F in the alpha  subunit from achieving a higher affinity than in the wild-type receptor alpha -delta interface.

We also examined the influence of the a Y93F and V188K mutations on alpha -conotoxin M1 affinity when the receptor is assembled from four distinct subunits as alpha 2beta gamma delta , rather than as alpha 2beta gamma 2 or alpha 2beta delta 2. alpha -Conotoxin M1 affinity for the alpha delta site is slightly higher, whereas the affinity for the alpha gamma site is slightly lower in the alpha 2beta gamma delta pentamer, compared with the pentameric combinations of the three respective subunits (Table 2 and Fig. 5B). Hence, the difference in KDvalues for the two sites is larger in the receptor assembled from four distinct subunits (alpha 2beta gamma delta ) than three (alpha 2beta gamma 2 or alpha 2beta delta 2). This may reflect longer range interactions between binding sites. Nevertheless, the influence of the alpha  subunit mutations is the same in the pentameric assemblies of four and three distinct subunits (Fig. 5B).

The alpha Y190T and alpha Y198T mutations show a predominant, but not completely selective, influence on reducing the affinity of the high affinity, alpha delta interface (Fig. 3A and Table 1). When these mutations are coexpressed as pentamers with the gamma  subunit triple mutant (gamma SYI), a reduction in alpha -conotoxin M1 affinity similar to that found for the delta  subunit is seen; the absolute affinities are enhanced over coexpression with wild-type gamma  because of the gamma SYI mutation (Fig. 6). Examination for the opposite situation, the substitution of gamma  subunit containing side chains into the delta  template, yielded diminished receptor expression with the mutant alpha  subunits and precluded a precise quantitation of affinity. Nevertheless, the influence of alpha Y190T and alpha Y198T mutations seems to depend on the binding affinity of alpha -conotoxin M1 and, here again, may reflect a slightly different binding position for alpha -conotoxin M1 between the high and low affinity binding sites.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Influence of alpha  subunit mutations of Y190T and Y198T on the binding of alpha -conotoxin M1 to receptors of alpha 2beta gamma 2 composition containing the three gamma  subunit mutations required to increase affinity. The gamma  subunit mutations (K34S, S111Y, and F172I) substitute three residues found at homologous positions in the delta  subunit into the gamma  subunit template. By substitution of three residues of the delta  subunit sequence into a gamma  subunit, high affinity for alpha -conotoxin M1 is conferred as well as the sensitivity to tyrosine substitutions in the alpha  subunit resulting in a loss of affinity.

    Discussion
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Subunit contributions to alpha -conotoxin M1 association. Radioiodination to form 125I-alpha -conotoxin M1 enables one to monitor directly the alpha -conotoxin association with various subunit combinations. High affinity binding where bound 125I-alpha -conotoxin M1 is retained by the receptor subunits after sedimentation is evident only for the alpha delta dimer. The same procedure shows alpha -bungarotoxin association with alpha  subunit monomers, alpha delta dimers, alpha gamma dimers, and alpha gamma alpha gamma tetramers. These findings not only document directly the site selectivity of alpha -conotoxin M1, but also reveal that alpha -conotoxin M1 requires an intact alpha delta subunit interface for high affinity binding.

Residues conferring alpha -conotoxin M1 selectivity. Previous studies have defined three residues in the delta  subunit (S36, Y113, and I178), which confer high affinity binding of alpha -conotoxin M1 to the alpha delta interface (Sine et al., 1995a). When substituted with the corresponding residues in the gamma  subunit (K34, S111, and F172), this triad of mutations in the delta  template confers an alpha -conotoxin M1 affinity approaching that of the gamma  subunit (Sine et al., 1995a). To account for alpha delta and alpha gamma interfaces showing nearly a 10,000-fold difference in alpha -conotoxin M1 affinity, either the gamma  subunit diminishes the influence of determinants on the alpha  subunit to alpha -conotoxin binding or determinants on the delta  subunit are major contributors to the high affinity of alpha -conotoxin M1. In turn, the delta  subunit could enhance affinity either directly through its own interactions with conotoxin or by altering the conformation of the alpha  subunit. Because the differences in alpha -conotoxin M1 affinity between alpha delta and alpha gamma interfaces are diminished and actually inverted for the T. californica receptor (Hann et al., 1994; Utkin et al., 1994; Groebe et al., 1995; Sine et al., 1995a) and affinity of the alpha epsilon subunit interface is intermediate to the alpha delta and alpha gamma interfaces in mouse (Sine S, unpublished observations), the gamma , delta , and epsilon  subunits likely contribute to stabilization of the alpha -conotoxin complex both directly and by affecting the conformations of the neighboring alpha  subunit.

To pursue the question of subunit contributions further, we examined individual residues in three regions in the alpha  subunit known to influence agonist and alkaloid antagonist binding to the receptor. Because several of the alpha -conotoxins such as M1 are relatively selective for the muscle subtype of receptor (i.e., alpha 1 subunit-containing receptors), we also relied on differences in the sequence between alpha 1 and the neuronal alpha  subunits (alpha 2, alpha 3, alpha 4, and alpha 7) of receptor. In the alpha 1 subunit, the region between residues 180 and 200 has been particularly well studied. Two tyrosines, Y190 and Y198, are conserved in all alpha  subunits, and their modification affects the binding of both agonists and antagonists (Tomaselli et al., 1991; O'Leary and White, 1992; Fu and Sine, 1994; O'Leary et al., 1994; Sine et al., 1994). Moreover, a diterpene antagonist, lophotoxin, actually conjugates with Y190 (Abramson et al., 1989). The Y190F and Y198F mutations have a marked influence on agonist and d-tubocurarine binding, but show little influence on alpha -conotoxin M1 association. However, Y93F enhances alpha -conotoxin affinity. Removal of aromaticity by substituting T for Y has a substantial influence on both alpha -conotoxin M1 (Table 1 and Figs. 3 and 6), and the non-peptide antagonists (Sine et al., 1994), particularly at the high affinity alpha delta interface. Thus, aromaticity may be required to stabilize the quaternary amine moiety as well as the cationic peptide.

Several further modifications of residues in this region showed that creating a positive charge at residue 188 markedly decreased binding affinity, whereas a negative charge at this position slightly enhanced affinity; these changes were evident only at the alpha gamma interface. Modification of residues between the two prolines at position 197 produced complex behavior: substitutions or deletions at position 194 were largely without influence, whereas substitutions at position 197 slightly lowered alpha -conotoxin M1 affinity. The T195E mutation reduced alpha -conotoxin M1 affinity selectively at the alpha delta interface. Unfortunately, we were unable to obtain reproducible binding with the T196E mutation. The cumulative influence of residues 194-197, when modified to residues found in neuronal receptors (Fig. 2), could account for part of the selectivity of alpha -conotoxin M1 for the muscle type of receptor.

The Y93F mutation enhances alpha -conotoxin M1 binding affinity at the low affinity, alpha gamma site, whereas substitution of serine decreases the affinity at this site (Fig. 4). Modifications of aromatic residues at positions 149 and 151 are without influence, whereas the D152N mutation selectively reduces the affinity at the alpha delta interface (Fig. 3). Hence, the three regions of linear sequence known to affect the affinity of agonists and nonpeptidic antagonists also influence alpha -conotoxin binding. However, the similarities of residue contributions to alpha -conotoxin M1 and other nonpeptidic antagonists apply to regional segments of sequence but not necessarily to the individual amino acids.

Relationship between alpha  subunit mutations and gamma /delta subunit mutations. We examined whether linkage relationships exist between mutations in the alpha  subunit and those in gamma  and delta  subunits or whether the determinants on each subunit act independently of each other as would be expected if they bound to different portions of the alpha -conotoxin molecule. A strong linkage relationship is apparent between S36 and I178 on the delta  subunit, where the individual substitutions, S36K or I178F, has a small or no influence on alpha -conotoxin KD values, yet when both substitutions are made, a marked loss in affinity or increase in KD evident (Sine et al., 1995a). Using a mutant cycle analysis (Carter et al., 1984) for mutations at corresponding positions 36 and 178 in the delta  subunit template, we may set the following cycle:
<AR><R><C></C><C>S<SUB>1</SUB></C></R><R><C>&dgr;<SUB><UP>S36,I178</UP></SUB></C><C>⇀</C><C>&dgr;<SUB><UP>K36,I178</UP></SUB></C></R><R><C>I<SUB>2</SUB>  ⇃ </C><C></C><C>⇃   I<SUB>1</SUB></C></R><R><C></C><C>S<SUB>2</SUB></C></R><R><C>&dgr;<SUB><UP>S36,F178</UP></SUB></C><C>⇀</C><C>&dgr;<SUB><UP>K36,F178</UP></SUB></C></R></AR>
Where
&OHgr;=<FR><NU>S<SUB>1</SUB></NU><DE>S<SUB>2</SUB></DE></FR>=<FR><NU>I<SUB>2</SUB></NU><DE>I<SUB>1</SUB></DE></FR>=<FR><NU>K<SUB><UP>SI</UP></SUB>K<SUB><UP>KF</UP></SUB></NU><DE>K<SUB><UP>SF</UP></SUB>K<SUB><UP>KI</UP></SUB></DE></FR>=142
Then
&OHgr;<SUP>‡</SUP>=<UP>RT ln</UP> &OHgr;=2.9 <UP>kcal/mol</UP>
In this formulation, the dissociation constants K, for alpha -conotoxin and the receptor site are subscripted by the residues at positions 36 and 178. S1, S2, I1, and I2 designate the ratio of dissociation constants for the species at the base of the arrow relative to the tip of the arrow. The values are represented as absolute values without reference to sign.

Hence, a comparatively large linkage or coupling energy is seen between positions 36 and 178 in the delta  subunit for the binding of alpha -conotoxin M1. When similar mutant cycles were constructed to relate mutations in the alpha  subunit with those in gamma  and delta  subunits, linkage relationships between the three gamma /delta positions at residues 34/36, 111/113, and 172/178 with residues 93 and 188 in the alpha subunit were not evident (Omega Dagger  <=  0.35 kcal/mol); rather, the energetic contributions to alpha -conotoxin M1 binding of residues in the alpha  subunit seem independent of those in the gamma  and delta  subunits (compare Fig. 5). Hence, the coupling energy contributing to alpha -conotoxin binding occurs within rather than between subunits. The independence of mutations between subunits indicate that distinct surfaces of the alpha -conotoxin molecule interact with the alpha  and gamma /delta subunit faces.

Our findings that the alpha gamma and alpha delta interfaces possess disparate affinities for alpha -conotoxin M1 and that certain residues in the alpha  subunit selectively affect binding at the gamma  or delta  interface, suggest that the amino acid contributions from the common alpha  subunit as well as the distinct gamma  and delta  subunits differ in the stabilization of alpha -conotoxin M1. Hence, the orientations of the bound alpha -conotoxin molecules at the two sites are likely to be distinct.

Recent x-ray crystallographic (Guddat et al., 1996; Hu et al., 1996) and NMR studies (Han et al., 1997) of alpha -conotoxin-G1, P1VA, and Pn1A show a triangular, wedgelike structure stabilized by the disulfide bonds between Cys3 and Cys8 and between Cys4 and Cys14. Fitting the sequence of alpha -conotoxin M1 into the structural template shows that the amino terminus (either Gly1 or the side chain of Arg2), Pro6, and Arg10 are found at the vertices of the triangle. The arginines at positions 2 and 10 are some 15 Å apart, suggesting that different receptor subunits could harbor the anionic sites that stabilize the cationic loci. Because, in addition to the amino terminus, only one cationic charge at position 10 is conserved as Arg or Lys among the alpha -conotoxins (Myers et al., 1991, 1993), structure modification of alpha -conotoxins and analysis of their binding to mutant receptors should yield further details on the orientation of the bound peptide.

    Acknowledgments

We thank Dr. Jon Lindstrom (University of Pennsylvania, Philadelphia, PA) for the generous gift of MAb166.

    Footnotes

Received December 1, 1997; Accepted January 12, 1998

1 Current affiliation: Yokohama City University, Yokohama, Japan.

2 Current affiliation: Centre National de la Recherche Scientifique UAR 6560, Institut Federatif de Recherche Jean Roche, Laboratoire de Biochemie, F-13916 Marseille Cedex 20, France.

This work was supported by United States Public Health Service Grants GM18360 (P.T.) and NS31744 (S.M.S.).

Send reprint requests to: Dr. Palmer Taylor, Dept. of Pharmacology, Basic Science Bldg./0636, University of California-San Diego, 9500 Gilman Dr., La Jolla, CA 93093-0636.

    Abbreviations

HEK, human embryonic kidney.

    References
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References


0026-895X/98/040787-08$3.00/0
MOLECULAR PHARMACOLOGY, 53:787-794 (1998).
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. E. Hibbs, T. T. Talley, and P. Taylor
Acrylodan-conjugated Cysteine Side Chains Reveal Conformational State and Ligand Site Locations of the Acetylcholine-binding Protein
J. Biol. Chem., July 2, 2004; 279(27): 28483 - 28491.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. McIntosh, L. Azam, S. Staheli, C. Dowell, J. M. Lindstrom, A. Kuryatov, J. E. Garrett, M. J. Marks, and P. Whiteaker
Analogs of {alpha}-Conotoxin MII Are Selective for {alpha}6-Containing Nicotinic Acetylcholine Receptors
Mol. Pharmacol., April 1, 2004; 65(4): 944 - 952.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
H. TERLAU and B. M. OLIVERA
Conus Venoms: A Rich Source of Novel Ion Channel-Targeted Peptides
Physiol Rev, January 1, 2004; 84(1): 41 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-W. Chi, K.-H. Park, J.-E. Suk, B. M. Olivera, J. M. McIntosh, and K.-H. Han
Solution Conformation of {alpha}A-conotoxin EIVA, a Potent Neuromuscular Nicotinic Acetylcholine Receptor Antagonist from Conus ermineus
J. Biol. Chem., October 24, 2003; 278(43): 42208 - 42213.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-L. Wang, F. Gao, N. Bren, and S. M. Sine
Curariform Antagonists Bind in Different Orientations to the Nicotinic Receptor Ligand Binding Domain
J. Biol. Chem., August 22, 2003; 278(34): 32284 - 32291.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Fruchart-Gaillard, B. Gilquin, S. Antil-Delbeke, N. Le Novere, T. Tamiya, P.-J. Corringer, J.-P. Changeux, A. Menez, and D. Servent
Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor
PNAS, February 20, 2002; (2002) 42699899.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Bren and S. M. Sine
Hydrophobic Pairwise Interactions Stabilize alpha -Conotoxin MI in the Muscle Acetylcholine Receptor Binding Site
J. Biol. Chem., April 21, 2000; 275(17): 12692 - 12700.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Cho, K. H. Mok, B. M. Olivera, J. M. McIntosh, K.-H. Park, and K.-H. Han
Nuclear Magnetic Resonance Solution Conformation of alpha -Conotoxin AuIB, an alpha 3beta 4 Subtype-selective Neuronal Nicotinic Acetylcholine Receptor Antagonist
J. Biol. Chem., March 17, 2000; 275(12): 8680 - 8685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Osaka, S. Malany, B. E. Molles, S. M. Sine, and P. Taylor
Pairwise Electrostatic Interactions between alpha -Neurotoxins and gamma , delta , and epsilon Subunits of the Nicotinic Acetylcholine Receptor
J. Biol. Chem., February 25, 2000; 275(8): 5478 - 5484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Quiram, J. J. Jones, and S. M. Sine
Pairwise Interactions between Neuronal alpha 7 Acetylcholine Receptors and alpha -Conotoxin ImI
J. Biol. Chem., July 9, 1999; 274(28): 19517 - 19524.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Prince and S. M. Sine
Acetylcholine and Epibatidine Binding to Muscle Acetylcholine Receptors Distinguish between Concerted and Uncoupled Models
J. Biol. Chem., July 9, 1999; 274(28): 19623 - 19629.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. L. Papineni, J. U. Sanchez, K. Baksi, I. U. Willcockson, and S. E. Pedersen
Site-specific Charge Interactions of alpha -Conotoxin MI with the Nicotinic Acetylcholine Receptor
J. Biol. Chem., June 22, 2001; 276(26): 23589 - 23598.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Fruchart-Gaillard, B. Gilquin, S. Antil-Delbeke, N. Le Novere, T. Tamiya, P.-J. Corringer, J.-P. Changeux, A. Menez, and D. Servent
Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor
PNAS, March 5, 2002; 99(5): 3216 - 3221.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugiyama, N.
Right arrow Articles by Taylor, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugiyama, N.
Right arrow Articles by Taylor, P.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics